Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
NCT ID: NCT03355625
Last Updated: 2022-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
33 participants
OBSERVATIONAL
2017-09-01
2019-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study is a substudy to the study entitled; "Coagulopathy During Extracorporeal Membrane Oxygenation" (pending Clinical Trial ID number).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coagulation Monitoring in Patients on Extracorporeal Membrane Oxygenation (Observational Study)
NCT03642912
Study of Immunity Dysfunction Induced by Extracorporeal Assistance (ECMO / ECLS)
NCT03262155
Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU Patients
NCT05958511
Hemostatic Disorders on Intensive Care Patients.
NCT04179357
Infection Surveillance in Intensive Care Patients
NCT00197847
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study is a substudy to the study entitled; "Coagulopathy During Extracorporeal Membrane Oxygenation" (pending Clinical Trial ID number).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aarhus
OTHER
Aarhus University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Camilla Mains Balle, Research fellow
Role: PRINCIPAL_INVESTIGATOR
Centre of Haemophilia and Thrombosis, Department of Clinical Biochemistry, Aarhus University Hospital
Anne-Mette Hvas, Professor, MD, PhD
Role: STUDY_CHAIR
Centre of Haemophilia and Thrombosis, Department of Clinical Biochemistry, Aarhus University Hospital
Anni Nørgaard Jeppesen, MD, PhD
Role: STUDY_CHAIR
Department of Anaesthesiology and Intensive Care Unit East, Aarhus University Hospital
Steffen Christensen, MD, PhD
Role: STUDY_CHAIR
Department of Anaesthesiology and Intensive Care Unit East, Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre of Haemophilia and Thrombosis, Department of Clinical Biochemistry, Aarhus University Hospital
Aarhus, , Denmark
Department of Anaesthesiology and Intensive Care Unit East, Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ECMO-Camilla
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.